Human papillomavirus self‐sampling: A tool in cancer prevention and sexual health promotion
Human papillomavirus self‐sampling: A tool in cancer prevention and sexual health promotion
复制标题
人乳头瘤病毒自我采样：预防癌症和促进性健康的工具
DOI：
10.1111/1467-9566.13421
复制
发表时间：
2021
影响因子：
2.9
通讯作者：
Rios, Lucy
中科院分区：
文献类型：
--
作者：
Mamo, Laura;Pérez, Ashley E.;Rios, Lucy
本文探讨了人乳头瘤病毒（HPV）自我采样作为预防宫颈癌的一种方法，以及自我采样试剂盒直接向美国消费者推广的方式。公共卫生，生物医学和健康技术越来越多地想象自我采样，允许个人收集自己的阴道标本，邮寄到实验室进行检测并接收交付的结果，作为宫颈癌预防和性健康促进的一部分。本文探讨了科学和生物医学的要求，用于配置的问题，需要这种解决方案和方式的人，公众和市场的建立。我们分析了科学文献，对临床医生和其他关键参与者的采访，以及直接面向消费者（DTC）公司的网站。HPV自我采样既是解决宫颈癌筛查中的不公平和差距的一种解决方案，也是解决那些已经参与身体监测和降低风险的自我项目的人的需求和需求的一种解决方案。这些多方向的生物医学趋势也揭示了性与性健康、预防宫颈癌和促进性健康是如何纠缠在一起的。虽然我们不想破坏HPV自我采样的潜力，但我们鼓励关注公平和护理，而不是商品化的市场，以加强“好”患者监测其健康的概念。
This article examines human papillomavirus (HPV) self‐sampling as an approach to cervical cancer prevention and the ways self‐sampling kits are promoted directly to consumers in the United States. Public health, biomedicine and health tech have increasingly imagined self‐sampling, which allows individuals to collect their own vaginal specimen, mail to a laboratory for testing and receive delivered results, as a component of cervical cancer prevention and sexual health promotion. This article examines the scientific and biomedical claims used to configure the problem in need of this solution and the ways persons, publics and markets are established. We analyse scientific literature, interviews with clinicians and other key actors, and websites of directly to consumers (DTC) companies. HPV self‐sampling is constructed as both a solution to inequities and gaps in cervical cancer screening and a solution to the wants and needs of those already engaged in self‐projects of body monitoring and risk reduction. These multidirectional biomedical tendencies also reveal how sexuality and sexual health and cervical cancer prevention and sexual health promotion are entangled objects. While we do not want to undermine the potential of HPV self‐sampling, we encourage a focus on equity and care and not commodified markets that reinforce notions of ‘good’ patients monitoring their health.